Abstract:Background: The extremely malignant tumour known as pancreatic cancer (PC) lacks efficient prognostic markers and treatment strategies. The microbiome is crucial to how cancer develops and responds to treatment. Our study was conducted in order to better understand how PC patients' microbiomes influence their outcome, tumour microenvironment, and responsiveness to immunotherapy. Methods: We integrated transcriptome and microbiome data of PC and used univariable Cox regression and Kaplan–Meier method for screening the prognostic microbes. Then intratumor microbiome-derived subtypes were identified using consensus clustering. We utilized LASSO and Cox regression to build the microbe-related model for predicting the prognosis of PC, and utilized eight algorithms to assess the immune microenvironment feature. The OncoPredict package was utilized to predict drug treatment response. We utilized qRT-PCR to verify gene expression and single-cell analysis to reveal the composition of PC tumour microenvironment. Results: We obtained a total of 26 prognostic genera in PC. And PC samples were divided into two microbiome-related subtypes: Mcluster A and B. Compared with Mcluster A, patients in Mcluster B had a worse prognosis and higher TNM stage and pathological grade. Immune analysis revealed that neutrophils, regulatory T cell, CD8 + T cell, macrophages M1 and M2, cancer associated fibroblasts, myeloid dendritic cell, and activated mast cell had remarkably higher infiltrated levels within the tumour microenvironment of Mcluster B. Patients in Mcluster A were more likely to benefit from CTLA-4 blockers and were highly sensitive to 5-fluorouracil, cisplatin, gemcitabine, irinotecan, oxaliplatin, and epirubicin. Moreover, we built a microbe-derived model to assess the outcome. The ROC curves showed that the microbe-related model has good predictive performance. The expression of LAMA3 and LIPH was markedly increased within pancreatic tumour tissues and was linked to advanced stage and poor prognosis. Single-cell analysis indicated that besides cancer cells, the tumour microenvironment of PC was also rich in monocytes/macrophages, endothelial cells, and fibroblasts. LIPH and LAMA3 exhibited relatively higher expression in cancer cells and neutrophils. Conclusion: The intratumor microbiome-derived subtypes and signature in PC were first established, and our study provided novel perspectives on PC prognostic indicators and treatment options.

Pan-cancer atlas of tumor-resident microbiome, immunity and prognosis

Comprehensive analysis of microbiota signature across 32 cancer types

The Pan-Cancer Landscape of Abnormal DNA Methylation and Intratumor Microorganisms.

Exploring the patient-microbiome interaction patterns for pan-cancer

Intratumoral microbiota as a novel prognostic indicator in bladder cancer

Microbiota in Tumors: from Understanding to Application

Secure Hamming distance based record linkage with malicious adversaries

Current understanding of the intratumoral microbiome in various tumors

Unveiling the intratumoral microbiota within cancer landscapes

Integrated multi-omics identified the novel intratumor microbiome-derived subtypes and signature to predict the outcome, tumor microenvironment heterogeneity, and immunotherapy response for pancreatic cancer patients

Intratumor microbiota in cancer pathogenesis and immunity: from mechanisms of action to therapeutic opportunities

Pan-cancer analysis of microbiome quantitative trait loci

Intratumoral microbiota of pancreatic ductal adenocarcinoma impact patient prognosis by influencing tumor microenvironment

Abstract B030: Spatial coupling of microbes and immune cells shapes the tumor microenvironment in human cancers

Detecting microbiome species unique or enriched in 20+ cancer types and building cancer microbiome heterogeneity networks

Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy

The effect of the intratumoral microbiome on tumor occurrence, progression, prognosis and treatment

microbioTA : an atlas of the microbiome in multiple disease tissues of Homo sapiens and Mus musculus

Microbiota in tumors: new factor influencing cancer development

Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer

Abstract 5918: Interrogating host-intratumoral microbial interactions in pancreatic cancer